Author: Aruna Kaim

In his latest annual letter to shareholders, Adani Group Chairman Gautam Adani announced a major strategic pivot for the conglomerate. Having fully navigated the severe capital constraints and legal challenges of the past few years—including confirming that US legal proceedings are now entirely “behind us”—the group is transitioning from a defensive funding posture to aggressive, large-scale asset creation. Adani explicitly summarized the group’s new operational reality: “For us, the era of capital scarcity is over. Our challenge has evolved from ‘how do we fund it?’ to ‘how fast can we build it?'” To back this vision, the conglomerate scaled its…

Artificial intelligence has officially turned the complex, high-stakes domain of tax consulting into its first major corporate battleground. As the Indian arms of the Big Four (EY, PwC, Deloitte, and KPMG) rapidly scale up their AI ecosystems, the traditional corporate workflow of navigating direct tax, GST, and customs regulations is fundamentally transforming. The core driver of this shift is volume and automation. This year, Price Waterhouse & Co (PwC) has already crossed 1.3 million internal queries on its AI system, with query volumes growing by an aggressive 30% every 45 days. In response, the industry is witnessing a structural overhaul…

A major governance standoff is brewing at the top of India’s largest conglomerate. Following a high-level board meeting at Bombay House, Tata Trusts Chairman Noel Tata has put the reappointment of Tata Sons Chairman N. Chandrasekaran (Chandra) on hold. While Chandrasekaran’s current term runs until February 2027, Noel Tata asserted that discussing a third five-year extension is premature until three massive, unresolved structural and operational issues are addressed. The Three Flashpoints Delaying the Extension 1. The Tata Sons IPO Dilemma This is the most critical point of friction. The Reserve Bank of India (RBI) has classified Tata Sons as an…

Intel made major waves at Computex 2026 in Taipei by launching its next-generation Xeon 6+ processors, expanding its 800 Series Ethernet portfolio, and detailing its upcoming Crescent Island data center GPU. The new silicon lineup is engineered specifically to tackle data center density, power limitations, and the heavy orchestration demands of modern, agentic AI workloads. Intel Xeon 6+: Performance Density for Agentic AI Built on the advanced Intel 18A process node, the Xeon 6+ processors are designed for cloud-native environments where throughput per core, latency predictability, and rack power limits are critical. Massive Core Counts: Features up to 288 Efficient-cores…

As a brutal summer heatwave takes hold, remote workers face a stressful daily dilemma: do you keep your 1.5-ton air conditioner running all afternoon to stay focused, or do you sweat it out to avoid an astronomical electricity bill? Running an AC for a typical 9-hour workday can easily consume up to 8 units of power daily, turning your home office into an expensive luxury. By contrast, a modern personal or desert air cooler operates on water evaporation—drawing up to 90% less electricity—making it a highly budget-friendly alternative. AC vs. Air Cooler: Quick Comparison for WFH Users Feature / Metric…

To mark the 20th anniversary of the Republic of Gamers (ROG) brand, Asus has unveiled its limited-edition Edition 20 lineup at Computex 2026. The expansive collection features high-end PC components, pre-built desktops, cutting-edge displays, peripherals, and lifestyle products, all tied together by a striking black, red, and gold design theme. Extreme PC Components & Power Delivery ROG Crosshair X870E Edition 20 Motherboard: A highly unconventional board featuring an integrated all-in-one liquid cooling system for both the CPU and VRMs. It includes a unique dual 6.67-inch AMOLED display setup and supports up to nine M.2 storage slots. ROG Astral GeForce RTX…

The upcoming Vivo X Fold 6 could bring massive upgrades to the foldable smartphone market, according to a leak from prominent tipster Digital Chat Station. Rumored to launch in China by the end of June 2026, the next-generation book-style foldable is tipped to deliver substantial boosts in battery capacity, processing power, and camera hardware. Key Expected Upgrades A Shift to MediaTek: In a departure from the Qualcomm Snapdragon 8 Gen 3 processor used in its predecessor (the X Fold 5), the Vivo X Fold 6 is rumored to be powered by MediaTek’s upcoming flagship Dimensity 9500 chipset. If true, this…

Hospital sector major Max Healthcare Institute Ltd. is flashing strong technical turnaround signals on the daily charts after undergoing a significant 24% correction from its peak. According to market experts and technical analysts, the stock has officially broken out of a structural descending trendline resistance, signaling that bulls are actively stepping in to wrest back control of the price action. The Technical Setup: Reversal Out of a Descending Trendline The healthcare heavyweight had been locked in a corrective phase, charting a sequence of lower highs and lower lows that wiped nearly a quarter of its valuation. However, the latest daily…

Most investors live by a single financial metric. It is the number they learn before anything else about the stock market. It is plastered across every screener, highlighted in every brokerage note, and flashed continuously on business news channels. This number is stuck to a stock price like a price tag in a shop window, and most people read it exactly the same way: lower is better. We are, of course, talking about the P/E (Price-to-Earnings) ratio. In a market that has been grinding sideways or trapped in a grueling 20-month bearish cycle, the habit of opening a stock screener,…

The Indian pharmaceutical sector is undergoing a massive structural shift. There was a time when the Indian pharma narrative in the US was almost entirely bottlenecked by regulatory roadblocks: a USFDA inspection would lead to a warning letter, shipments would stall, and analysts would spend months calculating lost revenue and remediation timelines. Today, that narrative has completely transformed from defensive survival to aggressive global expansion. A prime example is Sun Pharma signing a definitive agreement to acquire Organon in an all-cash transaction valuing it at a massive enterprise value of $11.75 billion. While the sheer scale of the number is…